Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: Comparative observations of 125 patients treated at one institution
Dw. Andrews et al., Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: Comparative observations of 125 patients treated at one institution, INT J RAD O, 50(5), 2001, pp. 1265-1278
Citations number
88
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Background: Stereotactic radiosurgery (SRS) and, more recently, fractionate
d stereotactic radiotherapy (SRT) have been recognized as noninvasive alter
natives to surgery for the treatment of acoustic schwannomas. We review our
experience of acoustic tumor treatments at one institution using a gamma k
nife for SRS and the first commercial world installation of a dedicated lin
ac for SRT.
Methods: Patients mere treated with SRS on the gamma knife or SRT on the li
nac from October 1994 through August 2000. Gamma knife technique involved a
fixed-frame multiple shot/high conformality single treatment, whereas lina
c technique involved daily conventional fraction treatments involving a rel
ocatable frame, fewer isocenters, and high conformality established by nonc
oplanar arc bean shaping and differential beam weighting.
Results: Sixty-nine patients were treated on the gamma knife, and 56 patien
ts were treated on the linac, with 1 NF-2 patient common to both units. Thr
ee patients were lost to follow-up, and in the remaining 122 patients, mean
follow-up was 119 +/- 67 weeks For SRS patients and 115 +/- 96 weeks for S
RT patients. Tumor control rates were high (greater than or equal to 97%) f
or sporadic tumors in both groups but lower for NF-2 tumors in the SRT grou
p. Cranial nerve morbidities were comparably low in both groups, with the e
xception of functional hearing preservation, which was 2.5-fold higher in p
atients who received conventional fraction SRT.
Conclusion: SRS and SRT represent comparable noninvasive treatments for aco
ustic schwannomas in both sporadic and NF-2 patient groups. At 1-year follo
w-up, a significantly higher rate of serviceable hearing preservation was a
chieved in SRT sporadic tumor patients and may therefore be preferable to a
lternatives including surgery, SRS, or possibly observation in patients wit
h serviceable bearing. (C) 2001 Elsevier Science Inc.